Cyclerion Therapeutics, Inc. (CYCN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Cyclerion Therapeutics, Inc. (CYCN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CYCN Income Statement

Cyclerion Therapeutics, Inc. (CYCN) annual income statement — 9-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	1.02M	875K	93K	81K	1.81M	194K	0	0	0	0	0	0	0	0	306K	711K	533K	348K
Revenue Growth %	-100%	-100%	-43.24%	351.03%	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	-89.8%	1046.77%	300.75%	-13%
Cost of Goods Sold	0	730K	0	0	0	0	0	0	105K	44K	0	0	339K	572K	776K	0	10.22M	9.74M	10.46M	7.03M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3339.22%	1370.32%	1962.1%	2020.69%
Gross Profit	0	-730K	1.02M	875K	93K	81K	1.81M	194K	-105K	-44K	0	0	-339K	-572K	-776K	0	-9.91M	-9.03M	-9.93M	-6.68M
Gross Margin %	-	-	100%	100%	100%	100%	100%	100%	-	-	-	-	-	-	-	-	-3239.22%	-1270.32%	-1862.1%	-1920.69%
Gross Profit Growth %	-100%	-1001.23%	-43.24%	351.03%	188.57%	284.09%	-	-	69.03%	92.31%	100%	-	96.58%	93.67%	92.18%	100%	-9.48%	-14667.74%	17.01%	49.76%
Operating Expenses	1.77M	2.48M	1.86M	1.88M	1.76M	1.54M	1.3M	1.32M	1.28M	1.57M	1.79M	6.01M	1.53M	2.7M	3.68M	4.52M	3.52M	3.95M	4.41M	4.6M
OpEx % of Revenue	-	-	181.76%	214.97%	1897.85%	1898.77%	72.2%	681.44%	-	-	-	-	-	-	-	-	1150.65%	555.84%	827.96%	1322.13%
Selling, General & Admin	1.77M	2.48M	1.34M	1.53M	1.71M	1.5M	1.25M	1.24M	1.28M	1.57M	1.97M	2.13M	1.53M	2.7M	3.68M	3.1M	3.52M	3.95M	4.41M	4.6M
SG&A % of Revenue	-	-	131.12%	175.2%	1837.63%	1854.32%	69.1%	639.69%	-	-	-	-	-	-	-	-	1150.65%	555.84%	827.96%	1322.13%
Research & Development	0	730K	519K	348K	56K	36K	56K	81K	105K	44K	24K	580K	339K	572K	1.18M	1.41M	10.22M	9.74M	10.46M	7.03M
R&D % of Revenue	-	-	50.63%	39.77%	60.22%	44.44%	3.1%	41.75%	-	-	-	-	-	-	-	-	3339.22%	1370.32%	1962.1%	2020.69%
Other Operating Expenses	0	-730K	0	0	0	0	0	0	-105K	-44K	-200K	1000K	-339K	-572K	-1000K	0	-1000K	-1000K	-1000K	-1000K
Operating Income	-1.77M	-3.21M	-838K	-1.01M	-1.67M	-1.46M	502K	-1.13M	-1.38M	-1.62M	-1.79M	-6.01M	-1.86M	-3.27M	-4.46M	-4.52M	-13.43M	-12.98M	-14.34M	-11.29M
Operating Margin %	-	-	-81.76%	-114.97%	-1797.85%	-1798.77%	27.8%	-581.44%	-	-	-	-	-	-	-	-	-4389.87%	-1826.16%	-2690.06%	-3242.82%
Operating Income Growth %	-5.92%	-120.25%	-266.93%	10.82%	-20.81%	9.95%	127.97%	81.25%	25.79%	50.6%	59.71%	-33.13%	86.12%	74.78%	68.93%	59.96%	16.96%	3.07%	25.42%	48.19%
EBITDA	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.78M	-6M	-1.85M	-3.26M	-4.46M	-4.41M	-13.42M	-12.94M	-14.29M	-11.24M
EBITDA Margin %	-	-	-77.95%	-111.54%	-348.39%	-1764.2%	29.35%	-372.68%	-	-	-	-	-	-	-	-	-4384.31%	-1819.41%	-2681.05%	-3229.02%
EBITDA Growth %	-441.67%	-122.32%	-250.75%	-34.99%	75.49%	7.33%	129.8%	87.95%	28.49%	52.68%	60.07%	-36.12%	86.22%	74.81%	68.82%	60.78%	16.45%	1.53%	23.8%	46.98%
D&A (Non-Cash Add-back)	0	0	0	0	0	0	0	0	0	0	16.25K	16.25K	16.25K	16.25K	0	0	17K	48K	48K	48K
EBIT	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.79M	-2.71M	-1.86M	-3.27M	-4.46M	-4.41M	-13.43M	-12.98M	-14.34M	-11.29M
Net Interest Income	16K	32K	39K	30K	31K	28K	28K	42K	62K	76K	101K	107K	62K	88K	132K	111K	45K	0	-1K	-5K
Interest Income	16K	32K	39K	30K	31K	28K	28K	42K	62K	76K	101K	107K	62K	88K	132K	111K	45K	-	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	-	1K	5K
Other Income/Expense	16K	32K	39K	30K	1.35M	28K	28K	405K	62K	76K	101K	107K	62K	88K	132K	111K	45K	6K	3.56M	-5K
Pretax Income	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.69M	-5.91M	-1.8M	-3.19M	-4.32M	-4.41M	-13.39M	-12.98M	-10.78M	-11.29M
Pretax Margin %	-	-	-77.95%	-111.54%	-348.39%	-1764.2%	29.35%	-372.68%	-	-	-	-	-	-	-	-	-4375.16%	-1825.32%	-2021.58%	-3244.25%
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.69M	7.57M	-4.18M	-6.95M	-7.22M	-10.5M	-13.39M	-12.98M	-10.78M	-11.29M
Net Margin %	-	-	-77.95%	-111.54%	-348.39%	-1764.2%	29.35%	-372.68%	-	-	-	-	-	-	-	-	-4375.16%	-1825.32%	-2021.58%	-3244.25%
Net Income Growth %	-441.67%	-122.32%	-250.75%	-34.99%	75.49%	7.33%	131.29%	-109.56%	68.38%	77.83%	76.52%	172.08%	68.77%	46.42%	33.03%	7.03%	17.27%	3.14%	43.96%	39.99%
Net Income (Continuing)	-1.75M	-3.18M	-799K	-976K	-324K	-1.43M	530K	-723K	-1.32M	-1.54M	-1.69M	-5.91M	-1.8M	-3.19M	-4.32M	-4.41M	-13.39M	-12.98M	-10.78M	-11.29M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	1000K	-1000K	-1000K	-1000K	-1000K	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-2.87	-5.32	-1.75	-2.10	-0.77	-3.92	1.47	-2.03	-3.71	-4.34	-0.68	-3.36	-1.83	-3.11	-3.23	-4.97	-6.46	-6.28	-5.23	-5.22
EPS Growth %	-272.73%	-35.71%	-219.05%	-3.45%	79.25%	9.68%	316.18%	39.58%	-102.73%	-39.55%	78.95%	32.39%	71.67%	50.48%	38.24%	4.79%	28.7%	20.1%	57.51%	55.46%
EPS (Basic)	-2.87	-5.32	-1.75	-2.10	-0.77	-3.92	1.47	-2.03	-3.71	-4.34	-0.68	-3.36	-1.83	-3.11	-3.23	-4.97	-6.46	-6.28	-5.23	-5.22
Diluted Shares Outstanding	607.29K	600.71K	460.71K	460.71K	438.71K	365.14K	363.7K	360.86K	358.57K	356.29K	2.47M	2.44M	2.28M	2.18M	2.18M	2.07M	2.07M	2.07M	2.06M	2.16M
Basic Shares Outstanding	607.29K	600.71K	460.71K	460.71K	438.71K	365.14K	363.7K	360.86K	358.57K	356.29K	2.47M	2.44M	2.28M	2.18M	2.18M	2.07M	2.07M	2.07M	2.06M	2.16M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-